持续气道正压通气与睡眠呼吸暂停成人患者心血管事件及死亡的相关性:系统综述与荟萃分析
该系统综述与荟萃分析纳入10项随机临床试验(9项持续气道正压通气,1项自适应伺服通气),共7266例睡眠呼吸暂停患者,评估气道正压通气与对照相比对心血管事件和死亡的影响。结果显示,气道正压通气与主要不良心血管事件、心血管死亡或全因死亡均无显著关联,作者认为这些发现不支持以预防上述结局为目标使用气道正压通气。
要点
- 在睡眠呼吸暂停患者中,气道正压通气与主要不良心血管事件无显著关联(RR 0.77,95%CI 0.53-1.13)。
- 气道正压通气与心血管死亡(RR 1.15,95%CI 0.88-1.50)及全因死亡(RR 1.13,95%CI 0.99-1.29)均无显著关联。
- 持续气道正压通气与自适应伺服通气之间未发现关联差异(所有同质性P值>.24)。
核心结论
- 与无治疗或假治疗相比,气道正压通气与睡眠呼吸暂停患者心血管结局或死亡风险降低无关。
- 尽管气道正压通气对睡眠呼吸暂停有其他获益,这些发现不支持以预防上述结局为目标使用气道正压通气。
研究设计与样本
- 系统检索MEDLINE、EMBASE和Cochrane Library自建库至2017年3月的随机临床试验,纳入报告主要不良心血管事件或死亡的试验。
- 共纳入10项试验(9项持续气道正压通气,1项自适应伺服通气),睡眠呼吸暂停患者N=7266,平均年龄60.9岁(范围51.5至71.1岁),男性5847例(80.5%),平均(SD)体重指数30.0(5.2)。
- 由两名作者独立采用标准化表格提取数据,使用随机效应荟萃分析获得汇总相对危险度(RR)、危险差(RD)及95%CI。
主要发现
- 记录到356例主要不良心血管事件和613例死亡。
- 气道正压通气与主要不良心血管事件无显著关联(RR 0.77,95%CI 0.53-1.13,P=.19;RD -0.01,95%CI -0.03-0.01,P=.23)。
- 气道正压通气与心血管死亡无显著关联(RR 1.15,95%CI 0.88-1.50,P=.30;RD -0.00,95%CI -0.02-0.02,P=.87)。
- 气道正压通气与全因死亡无显著关联(RR 1.13,95%CI 0.99-1.29,P=.08;RD 0.00,95%CI -0.01-0.01,P=.51)。
- 急性冠脉综合征、卒中和心力衰竭的关联结果同样无显著差异。
关键数值与推荐
- 持续气道正压通气与自适应伺服通气之间无不同关联的证据(所有同质性P值>.24)。
- 荟萃回归未发现气道正压通气与不同呼吸暂停严重程度、随访时长或气道正压通气依从性水平下的结局存在关联(所有P值>.13)。
临床怎么用
- 原文结论指出,这些发现不支持以预防心血管结局或死亡为目标使用气道正压通气。
- 原文结论同时指出,气道正压通气对睡眠呼吸暂停有其他获益。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Sleep apnea (obstructive and central) is associated with adverse cardiovascular risk factors and increased risks of cardiovascular disease. Positive airway pressure (PAP) provides symptomatic relief, whether delivered continuously (CPAP) or as adaptive servo-ventilation (ASV), but the associations with cardiovascular outcomes and death are unclear. OBJECTIVE: To assess the association of PAP vs control with cardiovascular events and death in patients with sleep apnea. DATA SOURCES AND STUDY SELECTION: MEDLINE, EMBASE, and the Cochrane Library were systematically searched from inception date to March 2017 for randomized clinical trials that included reporting of major adverse cardiovascular events or deaths. DATA EXTRACTION AND SYNTHESIS: Two authors independently extracted data using standardized forms. Summary relative risks (RRs), risk differences (RDs) and 95% CIs were obtained using random-effects meta-analysis. MAIN OUTCOMES AND MEASURES: The main outcomes were a composite of acute coronary syndrome (ACS) events, stroke, or vascular death (major adverse cardiovascular events); cause-specific vascular events; and death. RESULTS: The analyses included data from 10 trials (9 CPAP; 1 ASV) of patients with sleep apnea (N = 7266; mean age, 60.9 [range, 51.5 to 71.1] years; 5847 [80.5%] men; mean [SD] body mass index, 30.0 [5.2]. Among 356 major adverse cardiovascular events and 613 deaths recorded, there was no significant association of PAP with major adverse cardiovascular events (RR, 0.77 [95% CI, 0.53 to 1.13]; P = .19 and RD, -0.01 [95% CI, -0.03 to 0.01]; P = .23), cardiovascular death (RR, 1.15 [95% CI, 0.88 to 1.50]; P = .30 and RD -0.00 [95% CI, -0.02 to 0.02]; P = .87), or all-cause death (RR, 1.13 [95% CI, 0.99 to 1.29]; P = .08 and RD, 0.00 [95% CI, -0.01 to 0.01]; P = .51). The same was true for ACS, stroke, and heart failure. There was no evidence of different associations for CPAP vs ASV (all P value homogeneity >.24), and meta-regressions identified no associations of PAP with outcomes for different levels of apnea severity, follow-up duration, or adherence to PAP (all P values > .13). CONCLUSIONS AND RELEVANCE: The use of PAP, compared with no treatment or sham, was not associated with reduced risks of cardiovascular outcomes or death for patients with sleep apnea. Although there are other benefits of treatment with PAP for sleep apnea, these findings do not support treatment with PAP with a goal of prevention of these outcomes.
引用
- Yu J, Zhou Z, McEvoy RD, et al. Association of Positive Airway Pressure With Cardiovascular Events and Death in Adults With Sleep Apnea: A Systematic Review and Meta-analysis. JAMA. 2017. PMID: 28697252. doi:10.1001/jama.2017.7967
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。